Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS · Delayed Price · Currency is USD
50.58
+0.90 (1.81%)
At close: Oct 9, 2025
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of $79.01 billion as of October 9, 2025. Its market cap has increased by 0.05% in one year.
Market Cap
79.01B
Enterprise Value
72.30B
Revenue
8.29B
Ranking
n/a
PE Ratio
28.83
Stock Price
$50.58
Market Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 2.50B to 79.01B, an increase of 3,059.23%. That is a compound annual growth rate of 10.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 79.28B | 8.19% |
| Dec 30, 2024 | 73.28B | 17.53% |
| Dec 29, 2023 | 62.35B | 48.41% |
| Dec 30, 2022 | 42.01B | -21.23% |
| Dec 30, 2021 | 53.34B | -39.09% |
| Dec 30, 2020 | 87.57B | 72.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 522.72M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 331.81M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 247.98M |